樑志天設計集團(02262.HK)3月30日舉行董事會會議以審批年度業績
格隆匯3月16日丨樑志天設計集團(02262.HK)公告,公司將於2020年3月30日(星期一)上午11時50分,假座香港九龍九龍灣宏泰道23號ManhattanPlace30樓舉行董事會會議,藉以商討下列事項:
1.考慮及批准集團截至2019年12月31日止年度的經審核綜合業績以及批准根據香港聯合交易所有限公司證券上市規則將予刊發的2019年年度業績的草擬公告;2.考慮派發末期股息(如有);3.考慮暫停辦理股東過户登記手續(如有需要);4.考慮召開公司應屆股東周年大會;及5.處理任何其他事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.